NO20020926L - Sf¶riske agglomerater av telitromycin, fremgangsmåte ved deres fremstilling og deres anvendelse for frestilling avfarmasöytiske former - Google Patents

Sf¶riske agglomerater av telitromycin, fremgangsmåte ved deres fremstilling og deres anvendelse for frestilling avfarmasöytiske former

Info

Publication number
NO20020926L
NO20020926L NO20020926A NO20020926A NO20020926L NO 20020926 L NO20020926 L NO 20020926L NO 20020926 A NO20020926 A NO 20020926A NO 20020926 A NO20020926 A NO 20020926A NO 20020926 L NO20020926 L NO 20020926L
Authority
NO
Norway
Prior art keywords
preparation
telithromycin
methods
pharmaceutical forms
spherical agglomerates
Prior art date
Application number
NO20020926A
Other languages
English (en)
Other versions
NO322622B1 (no
NO20020926D0 (no
Inventor
Jean-Yves Godard
Valerie Rognon-Ravaux
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9549351&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20020926(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20020926D0 publication Critical patent/NO20020926D0/no
Publication of NO20020926L publication Critical patent/NO20020926L/no
Publication of NO322622B1 publication Critical patent/NO322622B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20020926A 1999-08-26 2002-02-26 Fremgangsmate for fremstilling av sfaeriske agglomerater av telitromycin, og deres anvendelse for fremstilling av farmasoytiske former. NO322622B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910810A FR2797875B1 (fr) 1999-08-26 1999-08-26 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques
PCT/FR2000/002393 WO2001014393A2 (fr) 1999-08-26 2000-08-28 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques

Publications (3)

Publication Number Publication Date
NO20020926D0 NO20020926D0 (no) 2002-02-26
NO20020926L true NO20020926L (no) 2002-02-26
NO322622B1 NO322622B1 (no) 2006-11-06

Family

ID=9549351

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020926A NO322622B1 (no) 1999-08-26 2002-02-26 Fremgangsmate for fremstilling av sfaeriske agglomerater av telitromycin, og deres anvendelse for fremstilling av farmasoytiske former.

Country Status (34)

Country Link
US (1) US6825218B1 (no)
EP (1) EP1212336B1 (no)
JP (1) JP4871467B2 (no)
KR (1) KR100718222B1 (no)
CN (1) CN1183151C (no)
AR (1) AR025398A1 (no)
AT (1) ATE255590T1 (no)
AU (1) AU774385B2 (no)
BR (1) BR0013569B1 (no)
CA (1) CA2382497C (no)
CO (1) CO5190666A1 (no)
CZ (1) CZ2002594A3 (no)
DE (1) DE60006976T2 (no)
DK (1) DK1212336T3 (no)
EA (1) EA005080B1 (no)
ES (1) ES2209970T3 (no)
FR (1) FR2797875B1 (no)
HK (1) HK1049167B (no)
HR (1) HRP20020167B1 (no)
HU (1) HU229075B1 (no)
IL (2) IL148128A0 (no)
ME (2) MEP20108A (no)
MX (1) MXPA02001988A (no)
NO (1) NO322622B1 (no)
PL (1) PL204100B1 (no)
PT (1) PT1212336E (no)
RS (1) RS50433B (no)
SI (1) SI1212336T1 (no)
SK (1) SK287588B6 (no)
TR (1) TR200200506T2 (no)
TW (1) TWI272949B (no)
UA (1) UA73523C2 (no)
WO (1) WO2001014393A2 (no)
ZA (1) ZA200201599B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
EP1524966B1 (en) * 2002-07-19 2009-11-25 Aventis Pharma S.A. Taste masked oral composition of telithromycin
DK1610878T3 (da) * 2003-02-21 2014-12-01 Univ Bath Fremgangsmåde til fremstilling af partikler
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0130160B1 (en) * 1983-06-22 1988-01-07 The Ohio State University Research Foundation Small particle formation
JPH02227130A (ja) * 1989-02-28 1990-09-10 Taisho Pharmaceut Co Ltd 球形微小凍結粒子の製造法
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
ES2209970T3 (es) 2004-07-01
EP1212336B1 (fr) 2003-12-03
BR0013569A (pt) 2002-05-14
FR2797875B1 (fr) 2001-10-19
TWI272949B (en) 2007-02-11
PL353137A1 (en) 2003-10-20
TR200200506T2 (tr) 2002-08-21
HK1049167B (zh) 2005-08-19
NO322622B1 (no) 2006-11-06
ZA200201599B (en) 2003-04-30
AU7018100A (en) 2001-03-19
HUP0202842A3 (en) 2003-03-28
UA73523C2 (uk) 2005-08-15
HU229075B1 (hu) 2013-07-29
JP4871467B2 (ja) 2012-02-08
WO2001014393A3 (fr) 2001-06-21
NO20020926D0 (no) 2002-02-26
PL204100B1 (pl) 2009-12-31
MEP20108A (en) 2010-06-10
AR025398A1 (es) 2002-11-27
CA2382497A1 (fr) 2001-03-01
AU774385B2 (en) 2004-06-24
CN1183151C (zh) 2005-01-05
HK1049167A1 (en) 2003-05-02
CZ2002594A3 (cs) 2002-09-11
MXPA02001988A (es) 2002-08-20
US6825218B1 (en) 2004-11-30
EP1212336A2 (fr) 2002-06-12
FR2797875A1 (fr) 2001-03-02
RS50433B (sr) 2009-12-31
IL148128A (en) 2006-10-31
KR100718222B1 (ko) 2007-05-15
YU13202A (sh) 2004-09-03
CN1371386A (zh) 2002-09-25
SI1212336T1 (en) 2004-04-30
BR0013569B1 (pt) 2014-02-25
PT1212336E (pt) 2004-04-30
HRP20020167B1 (en) 2006-06-30
KR20020033771A (ko) 2002-05-07
EA200200294A1 (ru) 2002-08-29
SK2532002A3 (en) 2002-09-10
HUP0202842A2 (hu) 2003-01-28
JP2003507484A (ja) 2003-02-25
HRP20020167A2 (en) 2003-06-30
DK1212336T3 (da) 2004-03-15
ME00112B (me) 2010-10-10
IL148128A0 (en) 2002-09-12
WO2001014393A2 (fr) 2001-03-01
CO5190666A1 (es) 2002-08-29
DE60006976D1 (de) 2004-01-15
EA005080B1 (ru) 2004-10-28
SK287588B6 (sk) 2011-03-04
CA2382497C (fr) 2011-06-28
ATE255590T1 (de) 2003-12-15
DE60006976T2 (de) 2004-10-21

Similar Documents

Publication Publication Date Title
NO20024176L (no) Farmasöytiske preparater inneholder derivater av 3-amino- azetidin, de nye derivater og deres fremstilling
NO20024175D0 (no) Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
DK1345910T3 (da) Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf
NO20010013D0 (no) Svovelsubstituerte sulfonylaminokarboksylsyre N-arylamider, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene
NO20015156L (no) 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
NO20015113D0 (no) Nye forbindelser, deres fremstilling og anvendelse
NO20014603L (no) Tienopyrimidinforbindelser, deres fremstilling og anvendelse
NO20014013D0 (no) 16-halogenepotilonderivater, fremgangsmater for fremstilling av dem og deres farmasoytiske anvendelse
NO20020811D0 (no) Sulfonylkarboksamidderivater, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler
AU4941101A (en) Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides,and diagnostic and therapeutic methods
NO20025357D0 (no) Antranylamider og deres anvendelse som legemidler
NO20042635L (no) 5-Sulfanyl-ñH-1,2,4-triazol-derivater og deres anvendelse som medisin
NO20005146D0 (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
NO20022680L (no) Farmasoytiske kombinasjoner og deres anvendelse ved behandling av gastrointestinale forstyrrelser
DK1161434T3 (da) Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
NO992102L (no) Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
NO20020926D0 (no) Sf¶riske agglomerater av telitromycin, fremgangsmåte ved deres fremstilling og deres anvendelse for frestilling avfarmasöytiske former
NO20016247D0 (no) Streptograminderivater, deres fremstilling og preparater inneholdende derivatene
NO20022022D0 (no) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
DK1353912T3 (da) 2-Arylimino-2,3-dihydrothiazolderivater, fremgangsmåderne til deres fremstilling og deres terapeutiske anvendelse
NO20043295L (no) Faste salt-benzazepinforbindelser og deres anvendelse ved fremstilling av farmasoytiske forbindelser
NO20020784D0 (no) Medikament for behandling av brudd
NO20024590D0 (no) Farmasöytiske preparater inneholdende oligosakkarider, de nye oligosakkarider samt deres fremstilling
DK1086077T3 (da) Hidtil ukendte antiestrogener, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
PT1305314E (pt) Agente terapeutico cristalino

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees